Dr. John Wahren provides intriguing insight into the use of a protein that was once thought to have no biological activity, as a way to treat diabetic complications.

EFTR: C-peptide as a Therapy for Patients with T1DM

Learn about scientific advances that lead to a better understanding of diseases and therapies. Interviews with scientists and clinicians will provide you with cutting-edge information, coming directly from the source.  Explore topics ranging from drug discovery and new FDA regulations to novel approaches to metabolic diseases (e.g., diabetes and heart disease). Hosted by Mercodia.

Medicine

Natural Sciences

Learn about scientific advances that lead to a better understanding of diseases and therapies. Interviews with scientists and clinicians will provide you with cutting-edge information, coming directly from the source. Explore topics ranging from drug discovery and new FDA regulations to novel approaches to metabolic diseases (e.g., diabetes and heart disease). Hosted by Mercodia.

Share EFTR: C-peptide as a Therapy for Patients with T1DM

Sign up to save your podcasts

EFTR: C-peptide as a Therapy for Patients with T1DM

EFTR: C-peptide as a Therapy for Patients with T1DM